Why the India-UK trade deal now needs a five-gate implementation ledger
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal.
Comment & Opinion
Adult epilepsy market to reach $17.bn across 7MM by 2035
Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing
Samsung Biologics: geographic diversification is a sound business decision
What Ojemda’s JCA reveals about new era of clinical HTA in Europe
Outsourcing gap widens: Europe pulls away from US in new drug manufacturing
EAN 2026: Bocunebart’s promise as migraine preventive in treatment-refractory patients
Surge in RMAT designations awarded by the FDA
